2CT7-2-EtO
 | |
| Clinical data | |
|---|---|
| Other names | 2CT7-2EtO; 2CT7-2-ETO; 2CT7-2ETO; 4-Propylthio-2-ethoxy-5-methoxyphenethylamine; 2-Ethoxy-4-propylthio-5-methoxyphenethylamine |
| Routes of administration | Oral[1][2] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | "Quick" or "fast"[1][2][3] |
| Duration of action | ~5 hours[1][2][3] |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C14H23NO2S |
| Molar mass | 269.40 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2CT7-2-EtO, also known as 4-propylthio-2-ethoxy-5-methoxyphenethylamine, is a psychedelic drug of the phenethylamine, 2C, and TWEETIO families related to 2C-T-7.[1][2][3] It is the derivative of 2C-T-7 in which the methoxy group at the 2 position has been replaced with an ethoxy group.[1][2][3]
According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, 2CT7-2-EtO's dose is 20 mg orally and its duration is about 5 hours.[1][2][3] It was said to have a "quick" or "fast" onset and to be very short-lived.[1][2][3] The effects of 2CT7-2-EtO have been reported to include modest but real closed-eye visuals.[1] In addition, it was said to cause an uncomfortable headache the next day that intuitively seemed to be an after-effect of the drug.[1]
The chemical synthesis of 2CT7-2-EtO has been described.[1]
2CT7-2-EtO was first described in the literature by Shulgin in PiHKAL in 1991.[1] It was developed and tested by Darrell Lemaire, with publication via personal communication with Shulgin.[2][4][5][6][7] The drug is a controlled substance in Canada under phenethylamine blanket-ban language.[8]
See also
[edit]References
[edit]- 1 2 3 4 5 6 7 8 9 10 11 Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. "One Tweetio related to 2C-T-7 has been made and evaluated. This is the 2-EtO-homologue of 2C-T-7, 2-ethoxy-5-methoxy-4-(n)-propylthiophenethyl-amine, or 2CT7-2ETO. The benzaldehyde (2-ethoxy-5-methoxy-4-(n-propylthio)benzaldehyde had a melting point of 69-71 °C, the nitrostyrene intermediate a melting point of 106-106.5 °C, and the final hydrochloride a melting point of 187-189 C. At the 20 milligram level, the effects were felt quickly, and the eyes-closed visuals were modest but real. It was very short-lived, with baseline recovery at about the fifth hour. The next day there was an uncomfortable headache which seemed on an intuitive level to be an after-effect of the compound."
- 1 2 3 4 5 6 7 8 Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived from the original on 13 July 2025.
- 1 2 3 4 5 6 Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. ISBN 978-3-03788-700-4. OCLC 858805226. Archived from the original on 21 August 2025.
- ↑ "Erowid Darrell Lemaire Vault". erowid.org. Retrieved 14 November 2025.
- ↑ Morris H (7 December 2016). "The Lazy Lizard School of Hedonism". Hamilton's Pharmacopeia. Season 1. Episode 6. Vice Media. Viceland.
- ↑ Nez H, Lemaire D (2010). "Notes About Psychoactive Compounds" (PDF). In Targ R, Radin D (eds.). Radiant Minds: Scientists Explore the Dimensions of Consciousness. Millay. pp. 201–207. ISBN 978-0-615-29633-3.
- ↑ Nez H, Lemaire D (Lazar) (1990). Certain Exotic Transmitters as Smart Pills or Compounds that Increase the Capacity for Mental Work in Humans: A Story About LAZAR as Told by Hosteen Nez (2nd ed.). Archived from the original (PDF) on 9 July 2001.
- ↑ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.